UK Court Sides With Genentech In Eye-Treatment Patent Suit
The U.K. Court of Appeal ruled Thursday that a treatment for macular degeneration developed by Regeneron Pharmaceuticals Inc. and Bayer Pharma AG infringes a patent held by Genentech Inc. and that...To view the full article, register now.
Already a subscriber? Click here to view full article